The Interventional Cardiology Devices market is valued at approximately $12.2 billion in 2020 and is expected to generate revenues of $18.1 billion in 2026, with a CAGR of 6.8% over the forecast period (2021-2027). Key growth drivers include increased adoption of minimally invasive surgery, increased worldwide prevalence of cardiovascular disease, and technological advances introduced in this field. The number of minimally invasive surgeries performed increased from 669.5 thousand in 2005 to 805 thousand in 2014. These procedures reduce patient trauma and ensure a faster recovery, resulting in shorter hospital stays. Therefore, high demand for new products with high accuracy and efficiency is expected to fuel the growth of the market during the forecast period.
A full report of Interventional Cardiology Devices Market available at https://www.orionmarketreports.com/interventional-cardiology-devices-market/4726/
Major Players
• Cook Medical Inc.
• Abbott Laboratories
• Boston Scientific Corporation
• Terumo Medical Corporation
• Medtronic plc
Interventional Cardiology Devices Market: Segmentation
By Product
• Angioplasty Balloons
• Angioplasty Stents
• Structural Heart Devics
• Catheters
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Other Devices
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
